Skip to content
  • Media
  • Investors
  • Media
  • Investors
  • TAMP Therapy Platform
    • Our Science
    • RenovoCath®
  • Physicians
    • Evidence
    • Resources
  • Patients
    • The Procedure
    • FAQs
    • Patient Stories
    • Physician Locator
  • About Us
    • Leadership
    • Board of Directors
    • Advisory Boards
  • Contact
  • TAMP Therapy Platform
    • Our Science
    • RenovoCath®
  • Physicians
    • Evidence
    • Resources
  • Patients
    • The Procedure
    • FAQs
    • Patient Stories
    • Physician Locator
  • About Us
    • Leadership
    • Board of Directors
    • Advisory Boards
  • Contact

Category: Clinicians

What PET/CT Reveals After Transarterial Microperfusion for Pancreatic Cancer Presented at SIR 2026 Annual Scientific Meeting, April 2026

https://renovorx.wpenginepowered.com/wp-content/uploads/2026/05/SIR_2026_TAMP_PET-CT_Abstract_2.pdf

Delivering therapy where it matters® Presented at SIO 2026 Annual Scientific Meeting’s Discovery Theater Panel Discussion

http://renovorx.com/wp-content/uploads/2026/03/Attachment-I-SIO-PowerPoint-1.pdf

Real-Time Intravascular Pressure Measurements During Double Balloon Catheter-Mediated Trans-Arterial Micro Perfusion to Optimize Drug Delivery in Solid Tumors Presented at SIO 2026 Annual Scientific Meeting

https://renovorx.wpenginepowered.com/wp-content/uploads/2026/02/2026_SIO_Poster_IV-pressure-wire-vs-external-transducer_16Dec2025.pdf

Intra-Arterial Gemcitabine vs Intravenous Gemcitabine: Pharmacokinetic and Pharmacodynamic Sub-study of the TIGeR-PaC Phase 3 Clinical Trial Presented at ASCO Gastrointestinal Cancers Symposium 2026, January 2026

Logo - ASCO Gastrointestinal Cancers Symposium

https://renovorx.wpenginepowered.com/wp-content/uploads/2026/01/2026_ASCO-GI_Poster_TIGeR-PaC-PK-study_Final-1.pdf

Pharmacodynamics of Intra-arterial vs Intravenous Gemcitabine in Locally Advanced Pancreatic Cancer: Results of a Phase III Randomized Clinical Trial Pharmacodynamics of Intra-arterial vs Intravenous Gemcitabine in Locally Advanced Pancreatic Cancer: Results of a Phase III Randomized Clinical Trial

https://renovorx.wpenginepowered.com/wp-content/uploads/2025/03/2025_SSO_ePoster_TIGeR-PaC-PK-study.pdf

Micro-CT Imaging Following Intra-Arterial Delivery of a Radiopaque Silicone Polymer Using a Double-Balloon Occlusion Catheter in Pigs: A Model to Analyze Tissue Penetration via the Trans-Arterial Micro Perfusion (TAMP) Technique Presented at 2025 Society of Interventional Oncology Annual Conference, February 2025

https://renovorx.wpenginepowered.com/wp-content/uploads/2025/02/2025_SIO_Presentation.pdf  

Intra-Arterial Gemcitabine vs IV Gemcitabine: Pharmacokinetic Sub-study of the TIGeR-PaC Phase 3 Clinical Trial Presented at ASCO Gastrointestinal Cancers Symposium, January 2025

https://renovorx.wpenginepowered.com/wp-content/uploads/2025/01/ASCO-GI-2025_Novelli-Agah_PK-Poster_final.pdf

Treatment of locally advanced pancreatic cancer using localized trans-arterial micro perfusion of gemcitabine: combined analysis of RR1 and RR2 Published in The Oncologist, July 2024

https://academic.oup.com/oncolo/advance-article/doi/10.1093/oncolo/oyae178/7720668

Mesenteric Venous Thrombosis as a Predictor of Target Artery Thrombosis and Trans-Arterial Micro Perfusion Treatment Completion Among Patients with Locally Advanced Pancreatic Cancer Presented at Society of Interventional Radiology Annual Scientific Meeting, March 2024

https://renovorx.wpenginepowered.com/wp-content/uploads/2025/02/SIR2024_Presentation_17-Mar-2024_draft-with-refs.pdf

Double-Balloon Catheter–Mediated Transarterial Chemotherapy Delivery in a Swine Model: A Mechanism Recruiting the Vasa Vasorum for Localized Therapies Published in the Journal of Vascular and Interventional Radiology, March 2024

https://www.jvir.org/article/S1051-0443%2824%2900238-0/fulltext

Next →

RenovoCath is FDA-cleared for targeted delivery of chemotherapy to selected sites in the peripheral vascular system. The company is studying the use of RenovoCath-delivered gemcitabine for treatment of LAPC in an ongoing clinical trial conducted under an IND.

Facebook-f X-twitter Linkedin-in Youtube

Menu

  • TAMP Therapy Platform
  • Our Science
  • RenovoCath®
  • Physicians
  • Evidence
  • Clinical Trials
  • Patients
  • The Procedure
  • FAQs
  • Patient Stories
  • Physician Locator
  • About
  • Leadership
  • Board of Directors
  • Advisory Boards
  • Contact
  • TAMP Therapy Platform
  • Our Science
  • RenovoCath®
  • Physicians
  • Evidence
  • Clinical Trials
  • Patients
  • The Procedure
  • FAQs
  • Patient Stories
  • Physician Locator
  • About
  • Leadership
  • Board of Directors
  • Advisory Boards
  • Contact
  • 2570 W. El Camino Real, Suite 640
    Mountain View, CA 94040
  • (650) 284-4433
  • info@renovorx.com
© 2026 RenovoRx®. All rights reserved.

Privacy Statement | Terms of Use